伴侶動物藥品市場－全球產業規模、佔有率、趨勢、機會和預測，依適應症、動物種類、配銷通路、地區和競爭格局分類，2020-2030年預測

2024年全球伴侶動物藥品市場規模為185.2億美元，預計2030年將以9.25%的複合年成長率成長至314.9億美元。該市場涵蓋用於治療、預防和控制寵物疾病的藥品和生物製品，包括藥物、疫苗和營養補充劑。推動該市場成長的主要因素包括：寵物飼養量的增加、寵物人性化趨勢的顯著發展導致寵物健康支出增加、寵物主人預防保健意識的提高以及獸醫學的不斷進步。

主要市場促進因素

全球寵物飼養量的不斷成長以及寵物日益擬人化，是推動伴侶動物藥品市場發展的重要因素。寵物主人越來越將寵物視為家庭成員，因此也更願意在寵物的健康和福祉方面投入大量資金。

主要市場挑戰

全球伴侶動物藥品市場擴張面臨的一大挑戰是研發成本高昂，加之嚴格的監管要求和漫長的獸藥核准流程，使得情況雪上加霜。這些因素共同阻礙了持續投資，延長了創新療法進入市場的時間，從而影響了該行業有效應對伴侶動物不斷變化的健康需求的能力。

主要市場趨勢

生物製劑和先進療法的日益普及標誌著伴侶動物藥物領域的深刻變革，使其超越了傳統的小分子藥物，轉向更具標靶性的干涉措施。這些創新療法，包括單株抗體和基因療法，在治療慢性複雜疾病（例如骨關節炎和各種癌症）方面，展現出更高的療效和精準度。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球伴侶動物藥品市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依適應症分類（傳染病、皮膚病、疼痛、骨科疾病、行為疾病、其他）
  • 依動物分類（狗、貓、馬、其他）
  • 按配銷通路（獸醫院和診所、零售藥局、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美伴侶動物藥品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲伴侶動物藥品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區伴侶動物藥品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲伴侶動物藥品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美伴侶動物藥品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球伴侶動物藥品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Zoetis Services LLC
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Virbac Taiwan Co., Ltd.
• Vetoquinol SA
• Dechra Pharmaceuticals Limited
• Chanelle Pharma
• KyoritsuSeiyaku Corporation

第16章：策略建議

第17章調查會社について,免責事項

The Global Companion Animal Pharmaceuticals Market, valued at USD 18.52 Billion in 2024, is projected to experience a CAGR of 9.25% to reach USD 31.49 Billion by 2030. The global companion animal pharmaceuticals market encompasses pharmaceutical and biological products developed to treat, prevent, and manage diseases in pets, including medications, vaccines, and supplements. This market's growth is primarily driven by increasing pet ownership, the notable trend of pet humanization leading to higher spending on animal health, rising awareness among owners regarding preventive care, and continuous advancements in veterinary medical science.

Key Market Drivers

The increasing global trend of pet ownership coupled with the growing humanization of pets represents a foundational driver for the companion animal pharmaceuticals market. Pet owners increasingly view their animals as integral family members, leading to a willingness to invest significantly in their health and well-being. This shift elevates the standard of care provided to pets, encompassing advanced medical treatments, preventive medications, and specialized therapies.

Key Market Challenges

A significant challenging factor impeding the expansion of the Global Companion Animal Pharmaceuticals Market involves the substantial costs associated with research and development, compounded by stringent regulatory requirements and a protracted approval process for new veterinary drugs. These elements collectively deter sustained investment and prolong the market entry of innovative treatments, thereby impacting the industry's capacity to effectively address the evolving health needs of companion animals. This extended development pipeline can delay critical advancements in medications, vaccines, and supplements.

Key Market Trends

The growing adoption of biologics and advanced therapeutics signifies a profound evolution in companion animal pharmaceuticals, moving beyond traditional small-molecule drugs to more targeted interventions. These innovative treatments, including monoclonal antibodies and gene therapies, offer enhanced efficacy and precision in managing chronic and complex diseases, such as osteoarthritis and various cancers. Their ability to address unmet medical needs by targeting specific disease pathways is driving demand.

Key Market Players

• Zoetis Services LLC
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Virbac Taiwan Co., Ltd.
• Vetoquinol S.A.
• Dechra Pharmaceuticals Limited
• Chanelle Pharma
• KyoritsuSeiyaku Corporation

Report Scope:

In this report, the Global Companion Animal Pharmaceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Pharmaceuticals Market, By Indication:

• Infectious diseases
• Dermatologic diseases
• Pain
• Orthopedic diseases
• Behavioural diseases
• Other

Companion Animal Pharmaceuticals Market, By Animal:

• Dogs
• Cats
• Horses
• Other

Companion Animal Pharmaceuticals Market, By Distribution Channel:

• Veterinary hospitals and clinics
• Retail pharmacies
• Others

Companion Animal Pharmaceuticals Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Companion Animal Pharmaceuticals Market.

Available Customizations:

Global Companion Animal Pharmaceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Companion Animal Pharmaceuticals Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication (Infectious diseases, Dermatologic diseases, Pain, Orthopedic diseases, Behavioural diseases, Other)
  • 5.2.2. By Animal (Dogs, Cats, Horses, Other)
  • 5.2.3. By Distribution Channel (Veterinary hospitals and clinics, Retail pharmacies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Companion Animal Pharmaceuticals Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Animal
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Companion Animal Pharmaceuticals Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Animal
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Companion Animal Pharmaceuticals Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Animal
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Companion Animal Pharmaceuticals Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Animal
      • 6.3.3.2.3. By Distribution Channel

7. Europe Companion Animal Pharmaceuticals Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Animal
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Companion Animal Pharmaceuticals Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Animal
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Companion Animal Pharmaceuticals Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Animal
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Companion Animal Pharmaceuticals Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Animal
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Companion Animal Pharmaceuticals Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Indication
      • 7.3.4.2.2. By Animal
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Companion Animal Pharmaceuticals Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Animal
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Companion Animal Pharmaceuticals Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Animal
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Companion Animal Pharmaceuticals Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Animal
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Companion Animal Pharmaceuticals Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Animal
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Companion Animal Pharmaceuticals Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Animal
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Companion Animal Pharmaceuticals Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Indication
      • 8.3.4.2.2. By Animal
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Companion Animal Pharmaceuticals Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Indication
      • 8.3.5.2.2. By Animal
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Companion Animal Pharmaceuticals Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Animal
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Companion Animal Pharmaceuticals Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Animal
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Companion Animal Pharmaceuticals Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Animal
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Companion Animal Pharmaceuticals Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Animal
      • 9.3.3.2.3. By Distribution Channel

10. South America Companion Animal Pharmaceuticals Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Indication
  • 10.2.2. By Animal
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Companion Animal Pharmaceuticals Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Indication
      • 10.3.1.2.2. By Animal
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Companion Animal Pharmaceuticals Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Indication
      • 10.3.2.2.2. By Animal
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Companion Animal Pharmaceuticals Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Indication
      • 10.3.3.2.2. By Animal
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Companion Animal Pharmaceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Services LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck & Co., Inc.
• 15.3. Boehringer Ingelheim International GmbH
• 15.4. Elanco Animal Health Incorporated
• 15.5. Virbac Taiwan Co., Ltd.
• 15.6. Vetoquinol S.A.
• 15.7. Dechra Pharmaceuticals Limited
• 15.8. Chanelle Pharma
• 15.9. KyoritsuSeiyaku Corporation

16. Strategic Recommendations

17. About Us & Disclaimer